KJM5230kap4

Embed Size (px)

Citation preview

  • 8/11/2019 KJM5230kap4

    1/20

    Receptors and Drug Action

    Receptors:

    Specific areas of cell membranes (proteins, glycoproteins)*

    When bound to ligand, positive or negative biological responce

    Ligand

    cellmembrane with receptor

    Biological responce

    Few ex. of free receptors in cytoplasma CellNucleus

    Cell membrane

    Organelles

    Cytoplasma

    Extracellular fluid

  • 8/11/2019 KJM5230kap4

    2/20

    Drugs that do not act on receptors:

    Antacida: CaCO3 + HCl

    Diuretica (osmotic)

    Akylating agents (cancer)

    ClN

    ClN

    Cl

    Nu

    N

    Cl

    Nu

    Drugs that do act on receptors:

    NO

    O

    OH

    ca. 5

    Acetylcholin(Neurotransmittor)

    NO

    O

    H2N

    Carbacholin

    N

    N

    Me

    H

    OO

    Acetylcholin Agonists

    Pilocarpine

    Acetylcholin Antagonists

    N

    O

    O

    OH

    Atropin

    O

    O

    N

    OH

    Cyclopentolat

    OO O

    R

    R'

    HN

    N

    O

    O

    OO O

    R

    R'

    HN

    N

    NNO

    O NH2

    ONN

    NH2

    O

    h

    Psoralenes

    Agonist:Binds to (have affinity for) receptor

    Binding leads to biolog. responce

    (Agonists have intrinsic activity / efficacy)

    Antagonist:

    Affinity for receptor

    No intrinsic activity

  • 8/11/2019 KJM5230kap4

    3/20

    Binding of ligand to receptor

    Covalent bond

    Ionic bond

    Hydrogen bond

    Hydrophobic interaction

    Covalent bond

    strong; 50-150 kcal/mol,

    Normally irreversible bonding

    ex. Acetylcholine esterase inhibitors

    Effector celleSynapse

    reseptor

    AcCh

    Nerve potensial

    AcCh

    AcCh (exess)

    AcCh-esterase

    Ch

    ChCh-acetyl-transferase

    AcCh

    Nerve cell

    N O

    O

    Acetylkolin(AcCh)

    Acetylkolin-esterase

    Kolin Acyltransfe rase

    N OH

    Kolin(Ch)

  • 8/11/2019 KJM5230kap4

    4/20

    Reversible inhibitors

    OH O O

    OH O

    OH

    NO

    O

    NHO

    k3(AcCh)

    AcCh

    Inhibitor

    Neostigmin Pyridostigmin

    Myastenia gravis (weak muscles, reduced sensitivity to Acetylcholine)O

    N O N

    O

    N O N

    OHO O

    NMe2OH O

    Me2N OH

    RO

    O

    Me2N

    RHO

    k3(inhibitor)

    More difficult to cleave

    Reversible inhibitor (drugs): k3(inhib) < k3(AcCh)

  • 8/11/2019 KJM5230kap4

    5/20

    Irreversible Inhibitors Not drugs, nerve gasses, insecticides etc.

    L

    PO

    OR

    R2

    OH O POH

    L

    OR

    R1O

    HO

    PO

    OR

    R1

    Aging

    OP

    OH

    R1 O

    Pralidoxim

    N

    N

    OH

    Me

    OH

    Pralidoxim

    motgift

    N

    N

    O

    Me

    P

    O OR

    R1

    Gen structur mustard gasses

    P

    O

    O

    N

    N

    Tabun

    FP

    O

    O

    Sarin

    LP

    O

    R1

    R2

    L: Leaving groupR1: alkoksyR2: alkyl, alkoksy, amino

    O

    O

    O

    O

    SP

    S

    O

    O

    Malation

    only insects

    O

    O

    O

    O

    SP

    O

    O

    O

    Malaoxon

    Act as mustard gassesnot tox.

  • 8/11/2019 KJM5230kap4

    6/20

    Ionic bond

    5-10 kcal/mol,

    Reversible bonding

    NO

    O

    OH

    Acetylcholin

    Hydrogen bond

    2-5 kcal/mol,

    Reversible bonding

    NO

    O

    O H

    Hydrophobic interaction

    0.5-1 kcal/mol,

    Reversible bonding

    OHO

    NH

    OH

    Anion

    cavity

    H-bind acceptor

    Lipophilic area

  • 8/11/2019 KJM5230kap4

    7/20

    The occupancy theory:

    The more receptors sites occupied by ligand, the stronger responce

    The rate theory:

    The more ligand-receptor interact / unit time, the stronger responce

    The induced-fit theory:

    ReceptorConformation ANo ligand bound

    + Agonist

    Agonist

    Responce

    + Antagonist

    Conformation B

    AntagonistResponce

    ConformationAorInactive conformation C

    The macromolecular pertubation theory:

    (induced fit + rate theory)

  • 8/11/2019 KJM5230kap4

    8/20

    The activation -agregation theory:

    Conformation B(Active)

    Responce

    Always dynamic equilibr.

    Responce+ Agonist

    Agonist

    Responce+Antagonist

    Antagonist

    Responce A+Inverse agonist

    Inv. Agonist

    Responce B(opposite of responce A)

  • 8/11/2019 KJM5230kap4

    9/20

    Dose-Responce Relationships

    A + B A-B [A] - equil. towards AB

    L + R L-R [L] - equil. towards LR ??

    L

    Biological responce

    R

    L-R R locked in membrane (do not move freely)

    L dissolved in extracellular fluid

    Reaction on solid - liquid interface

  • 8/11/2019 KJM5230kap4

    10/20

    [Agonist ligand]

    % biolog. effect

    50

    100

    EC50

    log [Agonist ligand]

    % biolog. effect

    50

    100

    EC50

    log [Agonist ligand]

    biolog. effect

    X Y

    Z

    Efficacy X = Efficacy Y (both can give 100% responce)

    Efficacy X> Efficacy Z (Z cam only give ca 30% responce)

    Efficacy (how high activity is possible)

    Potency (how easily is a given responce reached

    (ex EC50)

    Potency X > Potency YPotency X = Potency ZPotency Z > Potenzy Y

    EC50X and Y

    EC50Z

  • 8/11/2019 KJM5230kap4

    11/20

    Types of receptors

    Super- Endogenous General structures

    family ligands

    1 Fast neurotransmittors Ligand gated ion chanels

    ex. Acetylcholine

    2 Slow neurotransm. ex. noradrenalin G-Protein coupled receptors

    Hormones

    3 Insuline Enzyme coupled receptors

    Growth factors Catalytic receptors

    4 Steroid hormones Cytoplasmic receptors

    Thyreoid hormones

    Vitamin A, D

  • 8/11/2019 KJM5230kap4

    12/20

    Ligand gated ion chanels

    Fastest intracellular responce, s

    Binding of ligand - opening of chanel - ion (K+, Na+) in or out of cell - responce

    Ligands

    Fast neurotransmittors

    ex. Acetylcholine (nicotinic reseptors)

    Nobel prize chemistry 2003,Roderick MacKinnon for structural and mechanistic studies of ion channels.

    http://nobelprize.org/chemistry/laureates/2003/press.html

    Membrane(Phospholipides)

    Ion chanel

    Ligand binding sites

  • 8/11/2019 KJM5230kap4

    13/20

    G-Protein coupled receptors G-protein: Guanine nucleotide binding protein

    Extracellular fluid

    Intracellular fluid

    Ligand(Agonist)

    ReseptorConform. change

    GDP

    GTP

    G-protein

    GDP

    GTP

    Target

    GTP

    GDP+ P

    Responce

    HN

    N N

    N

    O

    OOP

    O

    O

    OP

    O

    O

    O

    OHHO

    n=1; GDPn=2; GTP

    n

    H2N

  • 8/11/2019 KJM5230kap4

    14/20

    Subtypes of G-proteins - Targets (Second messenger systems)

    Ion chanels: G12Na+/ H+exchange

    Enzyms: GiInhib. Adenylyl cyclase

    GsStimul. Adenylyl cyclaseGqStimul. Phospholipase C

    One ligand can bind to more than one type of G-prot. coupled reseptors

    second messenger pathways

    N

    N N

    N

    NH2

    OOP

    O

    O

    OP

    O

    O

    OP

    O

    O

    O

    OHHO

    ATP

    Adenylyl cyclase

    P O P

    N

    N N

    N

    NH2

    O

    OH

    c-ATP

    OP OO

    O

    Activate c-AMP dependent protein kinases (Phosphoryl. of proteins, i.e. enzymes)

    Various responces(ex. metabolism, cell division)

  • 8/11/2019 KJM5230kap4

    15/20

    Subtypes of G-proteins - Targets (Second messenger systems)

    Ion chanels: G12Na+/ H+exchange

    Enzyms: GiInhib. Adenylyl cyclase

    GsStimul. Adenylyl cyclaseGqStimul. Phospholipase C

    second messenger pathways

    Phopholipase C

    O

    O

    HOHO

    OOH

    P

    P

    PO

    O

    O

    O

    O

    O

    R'

    O

    R

    PIP2Phosphatidylinositol besphophate

    O

    O

    HOHO

    OOH

    P

    P

    P

    OH

    O

    O

    O

    O

    O

    R'

    O

    R

    O

    +

    IP3Inositol-1,4,5-triphosphate

    DAGDiacylglycerol

    Activate protein kinases

    Various processes in cell

    Release Ca2+

    Various processes in cell

    Several steps Li (Treatmen manic depression)

  • 8/11/2019 KJM5230kap4

    16/20

    Enzyme coupled receptors - Catalytic receptors

    1) Binding of Ligand2) Dimerisation

    of reseptor

    -OH -OH -OHTyr kinasedomain(Janus kinase)

    Phosphoryl of Tyr

    O P O P

    STATSprotein

    O P O P STATSprotein 1) Phosphoryl. of STAT2) Release of STAT in cytoplasma3) STATto cell nucleus4) Intitation of transcription

    STAT:Signal transducers and activators of transcription

    Ligands: Peptide hormones

  • 8/11/2019 KJM5230kap4

    17/20

    Cytoplasmic receptors

    (not bound to cell membranes)

    DNA

    DNAmRNA

    Protein

    Responce

    HSP-90

    Cell membrane

    Cytoplasma

    Lipophil. ligand thru cell membrane

    HSP-90

    Cell nucleus

    (HSP-90: Heat shock protein)

  • 8/11/2019 KJM5230kap4

    18/20

    Receptor subtypes

    Most receptor classes - several sub-types

    Each subtypes - differend A(nta)gonists

    Sub types cholinerge reseptors

    Nicotinerge

    receptors

    Muscarinerge

    receptors

    O H

    N

    N

    HO

    H

    O

    HO

    N

    CNS

    Effektor celleRese ptor

    Synapse

    Acetylkolin

    Noradrenalin

    Det somatiske nervesystem Det autonome nervesystem

    CNS CNS

    Det sympatisk enervesystem

    Det parasympatisknervesystem

    ganglion

    4.3

    5.9

    M1: G-Protein coupled receptors

    Stimulate phopholipase A

    M2: G-Protein coupled receptors

    Inhib. adenylyl cyclase

    Nmuscle: Ligand gated ion chanelsIncr. Na+/Ca2+

    Nneuro: Ligand gated ion chanels

    Incr. Na+/Ca2+

    NO

    O

    OH

    ca. 5

    Acetylcholin(Neurotransmittor)

  • 8/11/2019 KJM5230kap4

    19/20

    Full responce

    Spare receptors

    Full agonist

    Weak responce

    Partial agonist

    Full responce

    Spare receptors - Partial agonist

    Absens of full agonist

    Responce = Agonist

    Presence of full agonist

    Responce = Antagonist

  • 8/11/2019 KJM5230kap4

    20/20

    Desensitizing

    Sensitizing

    Receptor and normal amount of ligand = agonist

    Overstimulated receptor

    Receptor and normal amount of ligand = Antagonist

    Overstimulated receptor